PBH
Prestige Consumer Healthcare Inc. · Healthcare · Medical - Pharmaceuticals
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +0.9% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 100 | -6 | 34.03M | $1.61B | +5 | −12 |
| Q1 2026 | 110 | -5 | 35.15M | $2.08B | +6 | −12 |
| Q4 2025 | 116 | -2 | 39.06M | $2.41B | +1 | −2 |
| Q3 2025 | 19 | +1 | 21.74M | $1.36B | +2 | −2 |
| Q2 2025 | 16 | 0 | 19.92M | $1.59B | +1 | −1 |
| Q1 2025 | 13 | 0 | 5.41M | $464.71M | — | — |
| Q4 2024 | 13 | -1 | 5.31M | $414.35M | — | −1 |
| Q3 2024 | 13 | 0 | 3.46M | $249.12M | +1 | −1 |
| Q2 2024 | 13 | — | 3.54M | $243.72M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 7.97M | — | $636.17M | 0.0% | n/c | 1 | SEC ↗ ×17 |
| 2 | The Vanguard Group ✦ (passive) | 5.63M | — | $449.79M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passive) | 2.00M | +0.1% | $159.66M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 1.41M | +0.7% | $112.84M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | Fidelity (FMR) ✦ | 745.33K | — | $59.51M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 6 | T. Rowe Price ✦ | 531.61K | +14.0% | $42.45M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Norges Bank ✦ (passive) | 524.08K | 0.0% | $41.85M | 0.0% | Held | 5 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 405.80K | +10.2% | $32.40M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Fisher Asset Management ✦ | 305.63K | -6.8% | $24.40M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 286.61K | +45.3% | $22.89M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 11 | Millennium Management ✦ | 25.75K | +735.8% | $2.06M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | Arrowstreet Capital ✦ | 22.11K | New | $1.77M | 0.0% | New | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 21.03K | -30.0% | $1.68M | 0.0% | ▼ Trim | 5 | SEC ↗ ×5 |
| 14 | Wellington Management ✦ | 20.41K | -4.9% | $1.63M | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
| 15 | Gotham Asset Management ✦ | 11.83K | +57.8% | $944,865 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 6.57K | -82.2% | $524,375 | 0.0% | ▼ Trim | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Arrowstreet Capital | $1.77M | 0.0% |
Exited
| Citadel Advisors | $1.83M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 350 holders, 51.73M shares, $2.97B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.